🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ryan Huey

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-7887-8484
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial”.

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004822
N/A
1.4DataRank · unranked
44 citations

Bettzy Stephen, Daniel D. Karp, Sarina A. Piha‐Paul, David S. Hong, D Jain +10 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162
N/A
0DataRank · unranked
21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520
N/A
0DataRank · unranked
9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592
N/A
0DataRank · unranked
0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers

The Oncologist(2023)10.1093/oncolo/oyad085
N/A
0DataRank · unranked
28 citations

Amir A. Jazaeri, Shannon N. Westin, Curtis A. Pettaway, Solly George, Ryan Huey +8 more

Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad095
N/A
0DataRank · unranked
21 citations

Aakash Tushar Shah, Honey V. Reddi, Priyadarsini Dasari, James T. Topham, Hyunsoo Hwang +16 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1
N/A
0DataRank · unranked
0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Mutational and co-mutational landscape of early onset colorectal cancer

Biomarkers(2025)10.1080/1354750x.2024.2447089
N/A
0DataRank · unranked
24 citations

Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G. White, John Paul Shen +14 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002
N/A
0DataRank · unranked
22 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2575
N/A
0DataRank · unranked
9 citations

Weihong Xiao, Kangyu Lin, Chi Wut Wong, Michael Wotman, Emma B. Holliday +16 more